ID   FOSL2_RAT               Reviewed;         326 AA.
AC   P51145; Q6GXE4;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 2.
DT   24-JAN-2024, entry version 141.
DE   RecName: Full=Fos-related antigen 2;
DE            Short=FRA-2;
GN   Name=Fosl2; Synonyms=Fra-2, Fra2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Pineal gland;
RX   PubMed=7592994; DOI=10.1074/jbc.270.45.27319;
RA   Baler R.D., Klein D.C.;
RT   "Circadian expression of transcription factor Fra-2 in the rat pineal
RT   gland.";
RL   J. Biol. Chem. 270:27319-27325(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley; TISSUE=Osteoblast;
RX   PubMed=15299028; DOI=10.1074/jbc.m405549200;
RA   Chang W., Rewari A., Centrella M., McCarthy T.L.;
RT   "Fos-related antigen 2 controls protein kinase A-induced CCAAT/enhancer-
RT   binding protein beta expression in osteoblasts.";
RL   J. Biol. Chem. 279:42438-42444(2004).
RN   [3]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=19103603; DOI=10.1074/jbc.m808394200;
RA   Bailey M.J., Coon S.L., Carter D.A., Humphries A., Kim J.S., Shi Q.,
RA   Gaildrat P., Morin F., Ganguly S., Hogenesch J.B., Weller J.L., Rath M.F.,
RA   Moller M., Baler R., Sugden D., Rangel Z.G., Munson P.J., Klein D.C.;
RT   "Night/day changes in pineal expression of >600 genes: central role of
RT   adrenergic/cAMP signaling.";
RL   J. Biol. Chem. 284:7606-7622(2009).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Controls osteoclast survival and size (By similarity). As a
CC       dimer with JUN, activates LIF transcription (By similarity). Activates
CC       CEBPB transcription in PGE2-activated osteoblasts (PubMed:15299028).
CC       {ECO:0000250|UniProtKB:P47930, ECO:0000269|PubMed:15299028}.
CC   -!- SUBUNIT: Heterodimer (By similarity). Interacts with the BAF
CC       multiprotein chromatin-remodeling complex subunits SMARCB1 and SMARCD1
CC       (By similarity). Interacts with ARID1A and JUN (By similarity).
CC       {ECO:0000250|UniProtKB:P47930}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00978,
CC       ECO:0000269|PubMed:15299028}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain cortex. Expressed at night
CC       in pineal gland (at protein level). Also expressed in osteoblasts (at
CC       protein level). {ECO:0000269|PubMed:15299028,
CC       ECO:0000269|PubMed:19103603, ECO:0000269|PubMed:7592994}.
CC   -!- INDUCTION: In the pineal gland, exhibits night/day variations with a 4-
CC       fold increased expression at night (at protein level). Up-regulation is
CC       due to a large degree to the release of norepinephrine from nerve
CC       terminals in the pineal gland and cAMP signaling pathway. Nocturnally
CC       elevated expression is also observed in the brain cortex. In
CC       osteoblasts, up-regulated by PGE2 (at protein level).
CC       {ECO:0000269|PubMed:15299028, ECO:0000269|PubMed:19103603,
CC       ECO:0000269|PubMed:7592994}.
CC   -!- SIMILARITY: Belongs to the bZIP family. Fos subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U18913; AAC52310.1; -; mRNA.
DR   EMBL; AY622611; AAT52165.1; -; mRNA.
DR   PIR; I55459; I55459.
DR   RefSeq; NP_037086.1; NM_012954.1.
DR   AlphaFoldDB; P51145; -.
DR   SMR; P51145; -.
DR   iPTMnet; P51145; -.
DR   PhosphoSitePlus; P51145; -.
DR   PaxDb; 10116-ENSRNOP00000064213; -.
DR   GeneID; 25446; -.
DR   KEGG; rno:25446; -.
DR   AGR; RGD:2628; -.
DR   CTD; 2355; -.
DR   RGD; 2628; Fosl2.
DR   eggNOG; KOG1414; Eukaryota.
DR   InParanoid; P51145; -.
DR   OrthoDB; 4614365at2759; -.
DR   PRO; PR:P51145; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IDA:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IMP:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:RGD.
DR   GO; GO:0061144; P:alveolar secondary septum development; ISO:RGD.
DR   GO; GO:0030183; P:B cell differentiation; ISO:RGD.
DR   GO; GO:0042100; P:B cell proliferation; ISO:RGD.
DR   GO; GO:0060348; P:bone development; ISO:RGD.
DR   GO; GO:0030282; P:bone mineralization; ISO:RGD.
DR   GO; GO:0051216; P:cartilage development; ISO:RGD.
DR   GO; GO:0000902; P:cell morphogenesis; ISO:RGD.
DR   GO; GO:0002062; P:chondrocyte differentiation; ISO:RGD.
DR   GO; GO:0035988; P:chondrocyte proliferation; ISO:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0032964; P:collagen biosynthetic process; ISO:RGD.
DR   GO; GO:0032963; P:collagen metabolic process; ISO:RGD.
DR   GO; GO:0001661; P:conditioned taste aversion; IEP:RGD.
DR   GO; GO:1904606; P:fat cell apoptotic process; ISO:RGD.
DR   GO; GO:0045444; P:fat cell differentiation; ISO:RGD.
DR   GO; GO:0060613; P:fat pad development; ISO:RGD.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0003417; P:growth plate cartilage development; ISO:RGD.
DR   GO; GO:0048872; P:homeostasis of number of cells; ISO:RGD.
DR   GO; GO:0048873; P:homeostasis of number of cells within a tissue; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0002437; P:inflammatory response to antigenic stimulus; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; ISO:RGD.
DR   GO; GO:1901142; P:insulin metabolic process; ISO:RGD.
DR   GO; GO:0003334; P:keratinocyte development; ISO:RGD.
DR   GO; GO:0048286; P:lung alveolus development; ISO:RGD.
DR   GO; GO:0060427; P:lung connective tissue development; ISO:RGD.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0030225; P:macrophage differentiation; ISO:RGD.
DR   GO; GO:0070254; P:mucus secretion; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0036446; P:myofibroblast differentiation; ISO:RGD.
DR   GO; GO:0030223; P:neutrophil differentiation; ISO:RGD.
DR   GO; GO:0001865; P:NK T cell differentiation; ISO:RGD.
DR   GO; GO:0001503; P:ossification; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0030316; P:osteoclast differentiation; ISO:RGD.
DR   GO; GO:0009648; P:photoperiodism; IEP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0040014; P:regulation of multicellular organism growth; ISO:RGD.
DR   GO; GO:1904760; P:regulation of myofibroblast differentiation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:1904975; P:response to bleomycin; ISO:RGD.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0034097; P:response to cytokine; IEP:RGD.
DR   GO; GO:0032355; P:response to estradiol; IMP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; ISO:RGD.
DR   GO; GO:0140459; P:response to Gram-positive bacterium; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IMP:RGD.
DR   GO; GO:0035902; P:response to immobilization stress; IEP:RGD.
DR   GO; GO:0035962; P:response to interleukin-13; ISO:RGD.
DR   GO; GO:0098760; P:response to interleukin-7; ISO:RGD.
DR   GO; GO:1990823; P:response to leukemia inhibitory factor; ISO:RGD.
DR   GO; GO:0009416; P:response to light stimulus; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0048745; P:smooth muscle tissue development; ISO:RGD.
DR   GO; GO:0030217; P:T cell differentiation; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048771; P:tissue remodeling; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IMP:RGD.
DR   CDD; cd14721; bZIP_Fos; 1.
DR   Gene3D; 1.20.5.170; -; 1.
DR   InterPro; IPR000837; AP-1.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR046347; bZIP_sf.
DR   PANTHER; PTHR23351; FOS TRANSCRIPTION FACTOR-RELATED; 1.
DR   PANTHER; PTHR23351:SF25; FOS-RELATED ANTIGEN 2; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   PRINTS; PR00042; LEUZIPPRFOS.
DR   SMART; SM00338; BRLZ; 1.
DR   SUPFAM; SSF57959; Leucine zipper domain; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..326
FT                   /note="Fos-related antigen 2"
FT                   /id="PRO_0000076485"
FT   DOMAIN          124..187
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          1..39
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          111..131
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          126..128
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          129..136
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          193..244
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          289..326
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..32
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   MOD_RES         104
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P47930"
FT   MOD_RES         120
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   MOD_RES         200
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         230
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   MOD_RES         308
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   MOD_RES         320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   CROSSLNK        35
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   CROSSLNK        104
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   CROSSLNK        222
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   CROSSLNK        222
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   CROSSLNK        239
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P15408"
FT   CONFLICT        56
FT                   /note="T -> TT (in Ref. 1; AAC52310)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        89
FT                   /note="A -> R (in Ref. 1; AAC52310)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        154
FT                   /note="A -> T (in Ref. 1; AAC52310)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        201
FT                   /note="P -> S (in Ref. 1; AAC52310)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        206
FT                   /note="L -> V (in Ref. 1; AAC52310)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   326 AA;  35255 MW;  07DD44D47D0B790A CRC64;
     MYQDYPGNFD TSSRGSSGSP AHAESYSSGG GGQQKFRVDM PGSGSAFIPT INAITTSQDL
     QWMVQPTVIT SMSNPYPRSH PYSPLPGLAS VPGHMALPRP GVIKTIGTTV GRRRRDEQLS
     PEEEEKRRIR RERNKLAAAK CRNRRRELTE KLQAETEELE EEKSGLQKEI AELQKEKEKL
     EFMLVAHGPV CKISPEERRS PPTSGLQSLR GTGSAVGPVV VKQEPPEEDS PSSSAGMDKT
     QRSVIKPISI AGGGFYGEEP LHTPIVVTST PAITPGTSNL VFTYPSVLEQ ESPASPSESC
     SKAHRRSSSS GDQSSDSLNS PTLLAL
//
